We recently compiled a list of the Cathie Wood’s Stock Portfolio: 2025 Stock Picks. In this article, we are going to take a ...

CRISPR Therapeutics CRSP is expected to report fourth-quarter and full-year 2024 earnings later this month. The Zacks ...

Financial writer recommends Crispr Therapeutics AG as a strong buy due to cash position, drug pipeline, and promising ...

The world’s first genetically edited polo horses are here, all thanks to the efforts of a biotech firm based in Argentina.

No matter the market sentiment, gene editing is still a big deal for medical and pharmaceutical companies as well as patients and doctors. Two of the leading firms in the sector are CRISPR ...

ZUG, Switzerland and BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...

Genesis announced that it has completed its second successful human transplant with a genetically engineered pig kidney, with ...

Argentine scientists created the world's first genetically edited horse using CRISPR-Cas9 technology. Next projects include ...

Vertex Pharmaceuticals (VRTX) stock has performed strongly since the turn of the year, gaining 14.6% and vastly outperforming the healthcare ...

Domino’s Pizza Enterprises said it will provide an update on its Japan strategy at an investor day during the June half.